ask="1.2800"
ask_size="300"
average_daily_volume="63187"
bid="0.7300"
bid_size="300"
book_value="0.6940"
change="+0.0365"
change_from_200_day_moving_average="-0.3586"
change_from_50_day_moving_average="0.0250"
change_from_52_week_high="-6.8035"
change_From_52_week_low="0.2263"
change_in_percent="+3.2883%"
close="1.1465"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.1560"
ebitda="-17.60M"
eps_estimate_current_year="-1.0900"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="-0.8200"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.1800"
high_52_weeks="7.9500"
last_trade_date="1/25/2017"
last_trade_price="1.1465"
last_trade_size="200"
last_trade_time="3:39pm"
low="1.0990"
low_52_weeks="0.9202"
market_capitalization="18.79M"
moving_average_200_day="1.5051"
moving_average_50_day="1.1215"
name="Bioblast Pharma Ltd. - Ordinary"
notes="N/A"
one_year_target_price="9.0000"
open="1.1499"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-23.8277%"
percent_change_from_50_day_moving_average="+2.2310%"
percent_change_from_52_week_high="-85.5786%"
percent_change_from_52_week_low="+24.5925%"
previous_close="1.1100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5994"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.6100"
stock_exchange="NGM"
symbol="ORPN"
volume="49505"
weeks_range_52="0.9202 - 7.9500"
